Erector Spinae Plane Block for Acute Low Back Pain

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Montpellier

About this trial

Non-Specific low back pain (NSLB) is an important public health problem with a major economic and social impact. It is defined by the location of pain, between the lower rib margins and the lumbar vertebrae. Medical management of Non-Specific low back pain injury focuses on reducing pain and its consequences. Nowadays, no strategy has shown optimal effectiveness to improve outcome substantially. The ultrasound-guided erector spinae plane block (ESPB) is a well-known intermuscular compartment block. In the absence of red flag signs, ESPB can be performed for low back pain to reduce pain, decrease opiate requirements and limit emergency admissions for refractory pain. This study aims to evaluate the impact of the ESPB in patients suffering from NSLB.

Eligibility criteria

Qualifiers

Adult (≥ 18 years);

Non-specific low back pain (≤ 5 days);

Pain score (VAS) ≥ 5 (during mobilization);

Inability to walk easily (failure of the "Get Up and Go" test in less than 20 seconds).

Disqualifiers

Low back pain of known specific origin: spine surgery, spine trauma, discal hernia, facet joint, radicular (sciatica, cruralgia, meralgia paresthetica), muscle pain, cancer-related or rheumatological disease;

Referred or chronic pain;

Patients with opioids (acute or chronic pain and/or misuse);

Contraindication to regional anaesthesia;

Trial design

Treatments tested in this trial

  • Erector Spinae Plane Block with isotonic saline
  • Erector Spinae Plane Block with local anesthetic

Treatment groups

300 Participants
are divided into 2 treatment groups

Locations

This trial has no locations